IN VITRO METHOD FOR SCREENING, DIAGNOSIS AND/OR PROGNOSIS OF COLORECTAL CANCER

Patent number:

EP22382471

No items found.

The present invention refers a method for differentially screening, diagnosis and/or prognosis of colorectal cancer among men and women subjects, due to the sex disparities existing between them. In a preferred embodiment, the present invention is particularly focused on screening, diagnosis and/or prognosis early-onset colorectal cancer (EOCRC) which occurs in persons with less than 50 years of age.

Countries:

Spain

Regions:

Castille and Leon

Centers:

FUNDACION INSTITUTO DE ESTUDIOS CIENCIAS DE LA SALUD DE CASTILLA Y LEON IECSCYL IBSAL, FUNDACION IMDEA ALIMENTACION

Other entities:

Sectors:

Health

Subsectors:

Pharmaceuticals

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

Plasma expression profile analysis of metabolic health related genes in EOCRC patients showing sex intrinsic disparities.

Comments

Other related patents

Health

COMPOSITIONS FOR TREATING DISEASES RELATED TO L YSOME DISORDERS

Countries

Spain

Health

Use of telomerase reverse transcriptase for treatment of conditions associated with myocardial infarction

Countries

Spain

Health

NOVEL TARGET TO TREAT A METABOLIC DISEASE IN AN INDIVIDUAL

Countries

Spain

Get back to patents directory